Skip to content
LexBuild

Designation of Six Areas as High Intensity Drug Trafficking Areas

---
identifier: "/us/fr/2022-16095"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Designation of Six Areas as High Intensity Drug Trafficking Areas"
title_number: 0
title_name: "Federal Register"
section_number: "2022-16095"
section_name: "Designation of Six Areas as High Intensity Drug Trafficking Areas"
positive_law: false
currency: "2022-07-27"
last_updated: "2022-07-27"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Executive Office of the President"
document_number: "2022-16095"
document_type: "notice"
publication_date: "2022-07-27"
agencies:
  - "Executive Office of the President"
  - "Office of National Drug Control Policy"
fr_citation: "87 FR 45135"
fr_volume: 87
fr_action: "Notice of six High Intensity Drug Trafficking Areas (HIDTA) designations."
---

#  Designation of Six Areas as High Intensity Drug Trafficking Areas

**AGENCY:**

Office of National Drug Control Policy (ONDCP).

**ACTION:**

Notice of six High Intensity Drug Trafficking Areas (HIDTA) designations.

**SUMMARY:**

The Director of the Office of National Drug Control Policy designated six additional areas as High Intensity Drug Trafficking Areas (HIDTA). See *SUPPLEMENTARY INFORMATION* for locations.

**FOR FURTHER INFORMATION CONTACT:**

Questions regarding this notice should be directed to Shannon Kelly, National HIDTA Director, Office of National Drug Control Policy, Executive Office of the President, Washington, DC 20503; (202) 841-5240.

**SUPPLEMENTARY INFORMATION:**

The new areas are (1) Butte County in California as part of the Central Valley California HIDTA; (2) Vigo County in Indiana as part of the Indiana HIDTA; (3) Cumberland and Salem Counties in New Jersey as part of the Liberty Mid-Atlantic HIDTA; (4) Schenectady County in New York as part of the New York/New Jersey HIDTA; and (5) Lawrence County in Pennsylvania as part of the Ohio HIDTA.

*Authority:* 21 U.S.C. 1706(b)(1).

Dated: July 22, 2022.

Robert Kent,

General Counsel.